← Open Payments lookup

OMOLOLA AKINMADELO: Open Payments

NPI 1376188151 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$683 in 27 payments from 12 companies in 2025. Trend: 2023 $439 · 2024 $723 · 2025 $683

Food & beverage: $683
CompanyPaymentsAmount
GENZYME CORPORATION6$227
ABBVIE INC.4$86
Ardelyx, Inc.2$59
Regeneron Healthcare Solutions, Inc.2$45
Intercept Pharmaceuticals, Inc.2$44
Takeda Pharmaceuticals U.S.A., Inc.2$40
Gilead Sciences, Inc.2$38
PFIZER INC.2$36
Celltrion USA Inc.1$31
Phathom Pharmaceuticals, Inc.2$30

Products named: DUPIXENT, IBSRELA, OCALIVA, LINZESS, ENTYVIO, XELJANZ, VEGZELMA, VOQUEZNA.

Industry payments across DC — which companies pay providers there.